Inventor · disambiguated record
Ravi M. Shanker
Also filed as: SHANKER RAVI · SHANKER RAVI M · SHANKER RAVI MYSORE
48 granted patents·25 pending applications·487 citations·filing 1997–2021
98Inventor score
Top patents by PatentIndex Score
73 records- 0196US8703196B2Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymersBABCOCK WALTER C·Filed 2012·Granted Apr 22, 2014·50 cites·15 claims
- 0296US6548555B1Basic drug compositions with enhanced bioavailabilityPFIZER·Filed 2000·Granted Apr 15, 2003·123 cites·60 claims
- 0395US8202912B2Pharmaceutical compositions providing enhanced drug concentrationsCURATOLO WILLIAM J·Filed 2011·Granted Jun 19, 2012·29 cites·7 claims
- 0494US8236328B2Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymersBABCOCK WALTER C·Filed 2008·Granted Aug 7, 2012·30 cites·15 claims
- 0593US9572885B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Feb 21, 2017·8 cites·26 claims
- 0693US8883209B2Pharmaceutical solid dispersionsBABCOCK WALTER C·Filed 2010·Granted Nov 11, 2014·20 cites·11 claims
- 0793US8026286B2Pharmaceutical compositions providing enhanced drug concentrationsBEND RES INC·Filed 2000·Granted Sep 27, 2011·36 cites·8 claims
- 0892US8147872B2Pharmaceutical compositions of drugs and neutralized acidic polymersCREW MARSHALL·Filed 2005·Granted Apr 3, 2012·13 cites·15 claims
- 0990US10357455B2Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materialsBEND RES INC·Filed 2018·Granted Jul 23, 2019·3 cites·12 claims
- 1090US9555113B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Jan 31, 2017·5 cites·19 claims
- 1188US9855333B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted Jan 2, 2018·2 cites·25 claims
- 1287US9468604B2Pharmaceutical compositions of dispersions of drug and neutral polymersBEND RES INC·Filed 2014·Granted Oct 18, 2016·3 cites·19 claims
- 1385US8501231B2Pharmaceutical compositions providing enhanced drug concentrationsCURATOLO WILLIAM J·Filed 2012·Granted Aug 6, 2013·5 cites·10 claims
- 1484US8481081B2Pharmaceutical solid dispersionsBABCOCK WALTER C·Filed 2003·Granted Jul 9, 2013·15 cites·3 claims
- 1583US8173142B2Pharmaceutical compositions of drugs and neutralized acidic polymersCREW MARSHALL·Filed 2006·Granted May 8, 2012·2 cites·16 claims
- 1682US8796341B2Pharmaceutical compositions providing enhanced drug concentrationsBEND RES INC·Filed 2013·Granted Aug 5, 2014·3 cites·8 claims
- 1782US6399777B2Inclusion complexes of aryl-heterocyclic saltsPFIZER·Filed 2001·Granted Jun 4, 2002·14 cites·4 claims
- 1881US7115279B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitorsCURATOLO WILLIAM J·Filed 2001·Granted Oct 3, 2006·13 cites·76 claims
- 1980US6124457AProcess and intermediates for a β3 -adrenergic receptor agonistPFIZER·Filed 2000·Granted Sep 26, 2000·13 cites·10 claims
- 2079US9486410B2Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materialsPERLMAN MICHAEL E·Filed 2007·Granted Nov 8, 2016·3 cites·14 claims
- 2179US8980321B2Pharmaceutical compositions providing enhanced drug concentrationsBEND RES INC·Filed 2014·Granted Mar 17, 2015·2 cites·10 claims
- 2278US8828438B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductaseFRIESEN DWAYNE THOMAS·Filed 2006·Granted Sep 9, 2014·2 cites·9 claims
- 2378US8491933B2Pharmaceutical compositions of semi-ordered drugs and polymersBABCOCK WALTER C·Filed 2012·Granted Jul 23, 2013·1 cites·8 claims
- 2478US8389011B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitorsCREW MARSHALL D·Filed 2012·Granted Mar 5, 2013·3 cites·15 claims
- 2578US8048452B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitorBEND RES INC·Filed 2006·Granted Nov 1, 2011·2 cites·15 claims
- 2677US8257739B2Pharmaceutical compositions of semi-ordered drugs and polymersBABCOCK WALTER C·Filed 2003·Granted Sep 4, 2012·6 cites·15 claims
- 2777US6232304B1Inclusion complexes of aryl-heterocyclic saltsPFIZER·Filed 1997·Granted May 15, 2001·36 cites·36 claims
- 2876US8828442B2Pharmaceutical solid dispersionsBABCOCK WALTER C·Filed 2012·Granted Sep 9, 2014·2 cites·8 claims
- 2976US8197848B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitorsCREW MARSHALL D·Filed 2007·Granted Jun 12, 2012·2 cites·16 claims
- 3074US9023393B2Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materialsBABCOCK WALTER C·Filed 2004·Granted May 5, 2015·3 cites·16 claims
- 3174US7235259B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitorsPFIZER·Filed 2002·Granted Jun 26, 2007·8 cites·26 claims
- 3273US6706721B1N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 1999·Granted Mar 16, 2004·13 cites·12 claims
- 3372US8389006B2Pharmaceutical compositions of adsorbates of amorphous drugBABCOCK WALTER C·Filed 2008·Granted Mar 5, 2013·1 cites·7 claims
- 3470US7521456B2N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 2003·Granted Apr 21, 2009·3 cites·13 claims
- 3570US2018236078A1Compositions with a Rheological Modifier to Reduce Dissolution VariabilityDURECT CORP·Filed 2018·Application pending·0 cites
- 3670US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 3768US11065250B2Solid dosage forms of palbociclibPFIZER·Filed 2016·Granted Jul 20, 2021·1 cites·9 claims
- 3868US9907851B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2016·Granted Mar 6, 2018·0 cites·11 claims
- 3967US9445998B2Pharmaceutical dosage forms comprising a low-solubility drug and a polymerBEND RES INC·Filed 2014·Granted Sep 20, 2016·0 cites·7 claims
- 4065US10300142B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted May 28, 2019·0 cites·20 claims
- 4165US2006216351A1Pharmaceutical Compositions of Dispersions of Drugs and Neutral PolymersPFIZER·Filed 2006·Application pending·0 cites
- 4264US2016374945A1Pharmaceutical compositions of dispersions of drug and neutral polymersBEND RES INC·Filed 2016·Application pending·0 cites
- 4363US2017000733A1Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materialsBEND RES INC·Filed 2016·Application pending·0 cites
- 4462USRE47033EPharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materialsBEND RES INC·Filed 2017·Granted Sep 11, 2018·0 cites·16 claims
- 4562US7897175B2Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitorBEND RES INC·Filed 2003·Granted Mar 1, 2011·2 cites·13 claims
- 4660US2007190129A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2004·Application pending·0 cites
- 4759US9457095B2Pharmaceutical compositions providing enhanced drug concentrationsBEND RES INC·Filed 2015·Granted Oct 4, 2016·0 cites·9 claims
- 4859US6090942AProcess and intermediates for a β3 -adrenergic receptor agonistPFIZER·Filed 1999·Granted Jul 18, 2000·6 cites·10 claims
- 4959US2003228358A1Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materialsPFIZER·Filed 2003·Application pending·0 cites
- 5059US2003091643A1Pharmaceutical compositions of dispersions of drugs and neutral polymersFiled 2002·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ravi M. Shanker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →